The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Herpes Marker Testing Market Research Report 2025

Global Herpes Marker Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903932

No of Pages : 98

Ask Your Query

Synopsis

Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial diseases such as cold sores, whereas HSV-2 is responsible only for genital herpes. Diagnostic kits available for herpes marker testing include HSV-1 kits, HSV-2 kits and HSV-1/HSV-2 kits.

The global Herpes Marker Testing market was valued at US$ 74 million in 2023 and is anticipated to reach US$ 93 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

North American market for Herpes Marker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Herpes Marker Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Herpes Marker Testing in Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Herpes Marker Testing include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation and Merck KGaA, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Herpes Marker Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Marker Testing.

Report Scope

The Herpes Marker Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Herpes Marker Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Herpes Marker Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Abbott Laboratories
  • Abcam Plc
  • BioMérieux SA
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd.
  • DiaSorin S.p.A.
  • Quidel Corporation
  • Luminex Corporation
  • Merck KGaA
  • Qiagen N.V.
  • Norgen Biotek Corp.
  • Hologic Inc.
  • Bio Rad Laboratories Inc.
  • Meridian Bioscience Inc
  • Teco Diagnostics

Segment by Type

  • HSV-1
  • HSV-2
  • HSV-1/ HSV-2

Segment by Application

  • Research
  • Clinic

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Marker Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Herpes Marker Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 HSV-1
1.2.3 HSV-2
1.2.4 HSV-1/ HSV-2
1.3 Market by Application
1.3.1 Global Herpes Marker Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Herpes Marker Testing Market Perspective (2019-2030)
2.2 Herpes Marker Testing Growth Trends by Region
2.2.1 Global Herpes Marker Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Herpes Marker Testing Historic Market Size by Region (2019-2024)
2.2.3 Herpes Marker Testing Forecasted Market Size by Region (2025-2030)
2.3 Herpes Marker Testing Market Dynamics
2.3.1 Herpes Marker Testing Industry Trends
2.3.2 Herpes Marker Testing Market Drivers
2.3.3 Herpes Marker Testing Market Challenges
2.3.4 Herpes Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Herpes Marker Testing Players by Revenue
3.1.1 Global Top Herpes Marker Testing Players by Revenue (2019-2024)
3.1.2 Global Herpes Marker Testing Revenue Market Share by Players (2019-2024)
3.2 Global Herpes Marker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Herpes Marker Testing Revenue
3.4 Global Herpes Marker Testing Market Concentration Ratio
3.4.1 Global Herpes Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Herpes Marker Testing Revenue in 2023
3.5 Herpes Marker Testing Key Players Head office and Area Served
3.6 Key Players Herpes Marker Testing Product Solution and Service
3.7 Date of Enter into Herpes Marker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Herpes Marker Testing Breakdown Data by Type
4.1 Global Herpes Marker Testing Historic Market Size by Type (2019-2024)
4.2 Global Herpes Marker Testing Forecasted Market Size by Type (2025-2030)
5 Herpes Marker Testing Breakdown Data by Application
5.1 Global Herpes Marker Testing Historic Market Size by Application (2019-2024)
5.2 Global Herpes Marker Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Herpes Marker Testing Market Size (2019-2030)
6.2 North America Herpes Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Herpes Marker Testing Market Size by Country (2019-2024)
6.4 North America Herpes Marker Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Herpes Marker Testing Market Size (2019-2030)
7.2 Europe Herpes Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Herpes Marker Testing Market Size by Country (2019-2024)
7.4 Europe Herpes Marker Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Herpes Marker Testing Market Size (2019-2030)
8.2 Asia-Pacific Herpes Marker Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Herpes Marker Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Herpes Marker Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Herpes Marker Testing Market Size (2019-2030)
9.2 Latin America Herpes Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Herpes Marker Testing Market Size by Country (2019-2024)
9.4 Latin America Herpes Marker Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Herpes Marker Testing Market Size (2019-2030)
10.2 Middle East & Africa Herpes Marker Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Herpes Marker Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Herpes Marker Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Herpes Marker Testing Introduction
11.1.4 Abbott Laboratories Revenue in Herpes Marker Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Abcam Plc
11.2.1 Abcam Plc Company Detail
11.2.2 Abcam Plc Business Overview
11.2.3 Abcam Plc Herpes Marker Testing Introduction
11.2.4 Abcam Plc Revenue in Herpes Marker Testing Business (2019-2024)
11.2.5 Abcam Plc Recent Development
11.3 BioMérieux SA
11.3.1 BioMérieux SA Company Detail
11.3.2 BioMérieux SA Business Overview
11.3.3 BioMérieux SA Herpes Marker Testing Introduction
11.3.4 BioMérieux SA Revenue in Herpes Marker Testing Business (2019-2024)
11.3.5 BioMérieux SA Recent Development
11.4 Thermo Fisher Scientific, Inc.
11.4.1 Thermo Fisher Scientific, Inc. Company Detail
11.4.2 Thermo Fisher Scientific, Inc. Business Overview
11.4.3 Thermo Fisher Scientific, Inc. Herpes Marker Testing Introduction
11.4.4 Thermo Fisher Scientific, Inc. Revenue in Herpes Marker Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific, Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Herpes Marker Testing Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Herpes Marker Testing Business (2019-2024)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 DiaSorin S.p.A.
11.6.1 DiaSorin S.p.A. Company Detail
11.6.2 DiaSorin S.p.A. Business Overview
11.6.3 DiaSorin S.p.A. Herpes Marker Testing Introduction
11.6.4 DiaSorin S.p.A. Revenue in Herpes Marker Testing Business (2019-2024)
11.6.5 DiaSorin S.p.A. Recent Development
11.7 Quidel Corporation
11.7.1 Quidel Corporation Company Detail
11.7.2 Quidel Corporation Business Overview
11.7.3 Quidel Corporation Herpes Marker Testing Introduction
11.7.4 Quidel Corporation Revenue in Herpes Marker Testing Business (2019-2024)
11.7.5 Quidel Corporation Recent Development
11.8 Luminex Corporation
11.8.1 Luminex Corporation Company Detail
11.8.2 Luminex Corporation Business Overview
11.8.3 Luminex Corporation Herpes Marker Testing Introduction
11.8.4 Luminex Corporation Revenue in Herpes Marker Testing Business (2019-2024)
11.8.5 Luminex Corporation Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Herpes Marker Testing Introduction
11.9.4 Merck KGaA Revenue in Herpes Marker Testing Business (2019-2024)
11.9.5 Merck KGaA Recent Development
11.10 Qiagen N.V.
11.10.1 Qiagen N.V. Company Detail
11.10.2 Qiagen N.V. Business Overview
11.10.3 Qiagen N.V. Herpes Marker Testing Introduction
11.10.4 Qiagen N.V. Revenue in Herpes Marker Testing Business (2019-2024)
11.10.5 Qiagen N.V. Recent Development
11.11 Norgen Biotek Corp.
11.11.1 Norgen Biotek Corp. Company Detail
11.11.2 Norgen Biotek Corp. Business Overview
11.11.3 Norgen Biotek Corp. Herpes Marker Testing Introduction
11.11.4 Norgen Biotek Corp. Revenue in Herpes Marker Testing Business (2019-2024)
11.11.5 Norgen Biotek Corp. Recent Development
11.12 Hologic Inc.
11.12.1 Hologic Inc. Company Detail
11.12.2 Hologic Inc. Business Overview
11.12.3 Hologic Inc. Herpes Marker Testing Introduction
11.12.4 Hologic Inc. Revenue in Herpes Marker Testing Business (2019-2024)
11.12.5 Hologic Inc. Recent Development
11.13 Bio Rad Laboratories Inc.
11.13.1 Bio Rad Laboratories Inc. Company Detail
11.13.2 Bio Rad Laboratories Inc. Business Overview
11.13.3 Bio Rad Laboratories Inc. Herpes Marker Testing Introduction
11.13.4 Bio Rad Laboratories Inc. Revenue in Herpes Marker Testing Business (2019-2024)
11.13.5 Bio Rad Laboratories Inc. Recent Development
11.14 Meridian Bioscience Inc
11.14.1 Meridian Bioscience Inc Company Detail
11.14.2 Meridian Bioscience Inc Business Overview
11.14.3 Meridian Bioscience Inc Herpes Marker Testing Introduction
11.14.4 Meridian Bioscience Inc Revenue in Herpes Marker Testing Business (2019-2024)
11.14.5 Meridian Bioscience Inc Recent Development
11.15 Teco Diagnostics
11.15.1 Teco Diagnostics Company Detail
11.15.2 Teco Diagnostics Business Overview
11.15.3 Teco Diagnostics Herpes Marker Testing Introduction
11.15.4 Teco Diagnostics Revenue in Herpes Marker Testing Business (2019-2024)
11.15.5 Teco Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock